Back

Outcomes with oral anticoagulation resumption or discontinuation after an anticoagulation-related event in patients with atrial fibrillation

27 August 2023 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Oral anticoagulation: minimising bleeding Anticoagulants ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Gentian Denas

Motta di Livenza High Specialization Rehabilitation Hospital, Motta Di Livenza (Italy)

5 More presentations in this session

Presentation thumbnail
Effectiveness of high- versus low-dose four-factor prothrombin complex concentrate on hemostasis and thromboembolism in patients with oral factor Xa inhibitor-associated intracranial hemorrhage
Doctor W. Baker (Storrs, US)
Abstract Slides Video
Presentation thumbnail
DNA methylation of ADAMTS7 gene promoter in direct oral anticoagulant-induced bleeding in patients with atrial fibrillation
Miss N. Atzemian (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Factor XI inhibitors in early clinical trials: a meta-analysis
Doctor M. Galli (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Detection and management of clinically relevant drug-drug interactions with direct oral anticoagulants in ambulatory care: a prospective interventional study in community pharmacies
Mr A. Capiau (Ghent, BE)
Abstract Slides Video
Presentation thumbnail
Comparison of Antithrombotic Regimens after Left Atrial Appendage Occlusion: A Systematic Review and Network Meta-analysis
Doctor L. KUBRUSLY (Curitiba, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Oral anticoagulation: minimising bleeding

The Event

Event poster

ESC Congress 2023

27 August 2023 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Resumption of anticoagulation therapy among Non-Valvular Atrial Fibrillation (NVAF) patients with prior intracranial haemorrhage
thumbnail
Congress Presentation
Safety of discontinuing anticoagulation after atrial fibrillation ablation
thumbnail
Congress Presentation
An increase in stroke risk factors over time without arrhythmia recurrence does not require restarting anticoagulation in low-risk atrial fibrillation patients after successful ablation. (RESTART-AF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources